SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as it joins a new government-backed federal initiative designed to accelerate advanced nuclear reactor deployment for AI data centers. Investors are closely monitoring the company's progress toward reactor criticality and potential isotope commercialization, though debates persist within the community regarding the company's valuation, dilution, and timeline for achieving meaningful revenue.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is facing heightened investor scrutiny as the broader nuclear energy sector navigates regulatory challenges and volatile price action. While the community remains divided over the company's long-term commercialization timeline, bullish participants are looking for catalysts like new project contracts and government investment to break the stock's current consolidation phase.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors focus on the potential for European regulatory approval of Miplyffa, with the community actively tracking the upcoming EMA plenary agenda for a breakthrough. Sentiment is bolstered by bullish analyst upgrades and institutional interest, while discussions center on the stock's tight float and the strategic value of the drug's exclusivity protections.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is capturing significant investor attention as its critical role in powering AI data centers via a major natural gas infrastructure deal with Microsoft intersects with heightened geopolitical volatility. The community remains focused on the company's ability to maintain strong shareholder returns and dividend growth while navigating Middle East supply disruptions.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is currently experiencing a sharp rally fueled by renewed institutional interest and a broader "utility coin" rotation as investors pivot toward tokens with active corporate adoption. The community is actively debating the potential for an extended breakout, with many holders focusing on long-term enterprise integration and regulatory developments while cautioning others to manage risks during volatile market conditions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors anticipate imminent Phase 3 IZAR-1 clinical trial results, which management previously signaled would be ready within the month. The community is actively discussing the stock's potential as a buyout candidate and the clinical data's ability to trigger a significant re-rating, while expressing frustration over recent price volatility and insider sales ahead of the expected catalyst.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as investors weigh high-growth AI and semiconductor optimism against ongoing geopolitical volatility and concerns over persistent inflation. The community remains sharply divided between those using leveraged strategies to capitalize on tech momentum and those bracing for potential market pullbacks due to interest rate uncertainties and macro-level instability.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending as traders debate the impact of geopolitical instability in the Middle East and the volatility of crude oil prices. The community is actively discussing the potential for a breakout, with various perspectives on whether current supply-chain disruptions and energy sector momentum outweigh concerns about potential ceasefires and institutional trade patterns.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending as investors weigh significant contract wins against the backdrop of global energy instability and a cooling in regional geopolitical premiums. The community is actively discussing the impact of the pending Valaris merger on long-term valuation, the implications of fluctuating offshore day rates, and the company's progress in aggressively reducing its debt load.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to the company's recent acquisition of Siemens turbines, fueling speculation that a major hyperscale anchor tenant announcement is imminent. Community sentiment is polarized between those betting on an epic short squeeze driven by performance-based executive incentives and skeptics wary of dilution and the lack of confirmed contracts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: SkinHealth Systems Inc. (SKIN) Q2 Earnings Expected to Decline

SkinHealth Systems Inc. (SKIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SkinHealth Systems Inc. (SKIN) Upgraded to Strong Buy: Here's Why

SkinHealth Systems Inc. (SKIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?

Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds

AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds PR Newswire BOCA RATON, Fla., June 23, 2026 Top 25 Brands Capture 95% of AI Citation Share; 11,500 Independent Med Spas...

Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?

Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention

Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates

SkinHealth Systems Inc. (SKIN) delivered earnings and revenue surprises of +41.18% and -1.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics

The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Analysts

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has been given an average recommendation of 'Hold' by the eight analysts that are presently covering the stock, Marketbeat Ratings reports...

SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

$SKIN Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.05 up 37.50% YoY
• Reported revenue of $64.9M down -6.73% YoY
• SkinHealth Systems lowered its full-year 2026 revenue outlook to $280M, guiding Q2 2026 net sales $72M and Adjusted EBITDA $11M, reflecting continued pressure on device sales.

Skinhealth Systems, Inc. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.

SkinHealth Systems Inc. - Ordinary Shares - Class A

Coty’s Stock Crash Over Slowdown Caution Dampens Retail Sentiment on ULTA, ELF, SKIN 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.6855
Prev Close	$0.6759
Open	$0.6832
Dividend Yield	0.00%
50-Day Moving Average	$0.7343
Beta	1.37
Avg. Volume	1.33M
PE Ratio	-3.92

52-Week High	$2.69
52-Week Low	$0.5506
Market Capitalization	$88.84M
EPS (Annual)	-$0.1628
Price to Book	1.60
Revenue Per Employee	$490,685.16

Feed

News

Sentiment

Earnings

Fundamentals

Info